<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02413424</url>
  </required_header>
  <id_info>
    <org_study_id>201412080</org_study_id>
    <secondary_id>P30DK020579</secondary_id>
    <nct_id>NCT02413424</nct_id>
  </id_info>
  <brief_title>Metabolic Effects of Non-nutritive Sweeteners</brief_title>
  <acronym>NNS</acronym>
  <official_title>Metabolic Effects of Non-nutritive Sweeteners</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Urbana-Champaign</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Urbana-Champaign</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to examine whether sugar-replacement sweeteners that
      are currently on the market (ex. Sucralose, which is in Splenda) change how well the body
      works to control blood sugar.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators of this study have recently found that sucralose, the most commonly used
      non-nutritive sweetener (NNS), affects the glycemic response to an oral glucose tolerance
      test (OGTT) and potentiates glucose-stimulated insulin secretion in obese people who are not
      regular consumers of NNS. However, studies conducted in healthy lean adults, none of which
      control for previous use of NNS, show that sucralose does not affect glycemic or hormonal
      responses to the ingestion of glucose or other carbohydrates. Therefore, we do not know a)
      whether sucralose effects are limited to obese subjects, or are generalizable to lean people
      when controlling for prior history of NNS consumption, and b) mechanism(s) responsible for
      the acute effect of sucralose on glucose metabolism as we measured in obese subjects. The aim
      of this study is to determine the effects of an acute intake of sucralose on the metabolic
      response to an oral glucose tolerance test in lean and obese people.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak insulin secretion rate</measure>
    <time_frame>up to 5 hours after drinking a glucose load</time_frame>
    <description>Blood samples will be collected before and for 5 hours after drinking a glucose load to determine plasma insulin and C-peptide. Insulin secretion rate will be assessed using the minimal model of Breda and collaborators.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose rate of appearance</measure>
    <time_frame>up to 5 hours after drinking a glucose load</time_frame>
    <description>Blood samples will be collected before and for 5 hours after drinking a glucose load to determine glucose and glucose tracer:tracee ratios.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose-dependent insulinotropic polypeptide (GIP)</measure>
    <time_frame>up to 5 hours after drinking a glucose load</time_frame>
    <description>Blood samples will be collected before and for 5 hours after drinking a glucose load to determine GIP.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sucralose concentrations in plasma</measure>
    <time_frame>up to 310 min after drinking the sucralose load</time_frame>
    <description>Sucralose concentrations in plasma will be measured by using liquid chromatography-mass spectrometry.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Drink Sucralose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will drink sucralose 10 min before drinking a glucose load</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Drink Water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will drink water 10 min before drinking a glucose load</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Taste and spit Sucralose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will taste and spit up sucralose 10 min before drinking a glucose load</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sucralose</intervention_name>
    <description>60 ml of 2mM sucralose</description>
    <arm_group_label>Drink Sucralose</arm_group_label>
    <arm_group_label>Taste and spit Sucralose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water</intervention_name>
    <description>60 ml of water</description>
    <arm_group_label>Drink Water</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>glucose load</intervention_name>
    <arm_group_label>Drink Sucralose</arm_group_label>
    <arm_group_label>Drink Water</arm_group_label>
    <arm_group_label>Taste and spit Sucralose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI ≥ 30 kg/m2 or BMI ≥ 18 kg/m2 and BMI&lt;25 kg/m2

          -  &quot;insulin sensitive&quot;: based on the homeostasis model assessment of insulin resistance
             (HOMA-IR) &lt;3

        Exclusion Criteria:

          -  BMI ≥ 25 kg/m2 and BMI&lt;30 kg/m2

          -  HOMA-IR&gt;3

          -  Current smoker or quit smoking less than 6 months ago

          -  pregnancy or breastfeeding

          -  subjects who have malabsorptive syndromes, phenylketonuria, inflammatory intestinal
             disease, liver or kidney diseases, diabetes

          -  subjects who are taking any medication that might affect metabolism

          -  anemia

          -  regular use of non-nutritive sweeteners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marta Y Pepino, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Urbana-Champaign</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Illinois at Urbana Champaign</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Pepino MY, Tiemann CD, Patterson BW, Wice BM, Klein S. Sucralose affects glycemic and hormonal responses to an oral glucose load. Diabetes Care. 2013 Sep;36(9):2530-5. doi: 10.2337/dc12-2221. Epub 2013 Apr 30.</citation>
    <PMID>23633524</PMID>
  </reference>
  <reference>
    <citation>Brown RJ, de Banate MA, Rother KI. Artificial sweeteners: a systematic review of metabolic effects in youth. Int J Pediatr Obes. 2010 Aug;5(4):305-12. doi: 10.3109/17477160903497027. Review.</citation>
    <PMID>20078374</PMID>
  </reference>
  <reference>
    <citation>Margolskee RF, Dyer J, Kokrashvili Z, Salmon KS, Ilegems E, Daly K, Maillet EL, Ninomiya Y, Mosinger B, Shirazi-Beechey SP. T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15075-80. Epub 2007 Aug 27.</citation>
    <PMID>17724332</PMID>
  </reference>
  <reference>
    <citation>Swithers SE. Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol Metab. 2013 Sep;24(9):431-41. doi: 10.1016/j.tem.2013.05.005. Epub 2013 Jul 10.</citation>
    <PMID>23850261</PMID>
  </reference>
  <reference>
    <citation>Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014 Oct 9;514(7521):181-6. doi: 10.1038/nature13793. Epub 2014 Sep 17.</citation>
    <PMID>25231862</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2015</study_first_submitted>
  <study_first_submitted_qc>April 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2015</study_first_posted>
  <last_update_submitted>September 19, 2017</last_update_submitted>
  <last_update_submitted_qc>September 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sucralose</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

